Literature DB >> 25928757

Rationale for using data on biological variation.

Carmen Ricós, Virtudes Álvarez, Carmen Perich, Pilar Fernández-Calle, Joana Minchinela, Fernando Cava, Carmen Biosca, Beatriz Boned, Mariví Doménech, José Vicente García-Lario, Margarita Simón, Pilar Fernández Fernández, Jorge Diaz-Garzón, Elisabet González-Lao.   

Abstract

The aims of this study are: 1) to use the data included in the biological variation (BV) database to address the usability of BV estimates; and 2) to use different examples from the authors' laboratories to illustrate the use and the usefulness of BV data in laboratory medicine. The BV database is an essential tool for laboratory management. Examples of application of data derived from BV are given in this paper, such as analytical performance specifications that have been included in various quality control software designed to optimize operative rules; also they have been incorporated as acceptability limits in external quality assurance reports. BV data from pathological status are of utmost interest for monitoring patients and differences between the intra-individual coefficients of variation (CVI) estimated from healthy and patients are shown. However, for a number of analytes there are limited data available and for many there are no data, consequently new studies should be encouraged at an international level. In addition, developing international criteria to evaluate publications dealing with the estimation of BV components would be of the utmost interest. We are ready and willing to collaborate with such worthy initiatives. The first EFLM strategic conference on analytical performance specifications is an excellent opportunity for debating these ideas.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25928757     DOI: 10.1515/cclm-2014-1142

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  11 in total

1.  EQA/PT scheme to improve the equivalence of enzymatic results between mutual recognition laboratories in Beijing.

Authors:  Qing Tong; Shunli Zhang; Chang Zuo
Journal:  J Clin Lab Anal       Date:  2021-05-05       Impact factor: 2.352

2.  30-Year Longitudinal Study of Hematological Parameters of HIV-1 Negative Men Participating in Los Angeles Multicenter AIDS Cohort Study (MACS).

Authors:  Najib Aziz; Joshua J Quint; Elizabeth C Breen; John Oishi; Beth D Jamieson; Otoniel Martinez-Maza; Roger Detels
Journal:  Lab Med       Date:  2019-01-01

Review 3.  Uncertainty in measurement: A review of the procedures for determining uncertainty in measurement and its use in deriving the biological variation of the estimated glomerular filtration rate.

Authors:  Ian Farrance; Tony Badrick; Robert Frenkel
Journal:  Pract Lab Med       Date:  2018-04-05

Review 4.  Analytical Sigma metrics: A review of Six Sigma implementation tools for medical laboratories.

Authors:  Sten Westgard; Hassan Bayat; James O Westgard
Journal:  Biochem Med (Zagreb)       Date:  2018-06-15       Impact factor: 2.313

5.  Evaluation of biological variation of glycated hemoglobin and glycated albumin in healthy Chinese subjects.

Authors:  Libo Liang; He He; Yuping Zeng; Mei Zhang; Xia Wang; Xiaoling Li; Shanshan Liang; Zhenmei An; Hengjian Huang
Journal:  J Clin Lab Anal       Date:  2018-11-21       Impact factor: 2.352

6.  Determining biological variation of serum parathyroid hormone in healthy adults.

Authors:  Müjgan Ercan; Emiş Deniz Akbulut; Esin Avcı; Çiğdem Yücel; Esra Fırat Oğuz; Turan Turhan; Muhittin Serdar
Journal:  Biochem Med (Zagreb)       Date:  2019-08-05       Impact factor: 2.313

7.  Longitudinal Intra- and Inter-individual variation in T-cell subsets of HIV-infected and uninfected men participating in the LA Multi-Center AIDS Cohort Study.

Authors:  Najib Aziz; Beth D Jamieson; Joshua J Quint; Otoniel Martinez-Maza; Marianne Chow; Roger Detels
Journal:  Medicine (Baltimore)       Date:  2019-10       Impact factor: 1.817

8.  Labtracker+, a medical smartphone app for the interpretation of consecutive laboratory results: an external validation study.

Authors:  Judith M Hilderink; Roger J M W Rennenberg; Floris H M Vanmolkot; Otto Bekers; Richard P Koopmans; Steven J R Meex
Journal:  BMJ Open       Date:  2017-09-01       Impact factor: 2.692

9.  Standardization in laboratory medicine: Two years' experience from category 1 EQA programs in Spain.

Authors:  Carmen Ricós; Carmen Perich; Beatriz Boned; Elisabet González-Lao; Jorge Diaz-Garzón; Montserrat Ventura; Sandra Bullich; Zoraida Corte; Joana Minchinela; Fernando Marques; Margarita Simón; Virtudes Alvarez; José-Vicente García-Lario; Pilar Fernández-Fernández; Pilar Fernández-Calle
Journal:  Biochem Med (Zagreb)       Date:  2018-12-15       Impact factor: 2.313

10.  Biological variation of immunological blood biomarkers in healthy individuals and quality goals for biomarker tests.

Authors:  Najib Aziz; Roger Detels; Joshua J Quint; David Gjertson; Timothy Ryner; Anthony W Butch
Journal:  BMC Immunol       Date:  2019-09-14       Impact factor: 3.594

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.